Sharon Shachem

Title: The Innovative Contributions of Sharon Shachem

Introduction

Sharon Shachem is a notable inventor based in Alfey Menashe, Illinois. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target 5-HT receptors. With a total of two patents to her name, her work has the potential to impact the treatment of various central nervous system disorders.

Latest Patents

Shachem's latest patents include innovative compounds that serve as 5-HT receptor agonists and antagonists. The first patent focuses on arylpiperazinyl compounds, which are designed to treat conditions such as generalized anxiety disorder, ADD/ADHD, neural injury, stroke, and migraine. The invention details the synthesis and uses of these compounds, along with methods of preparation and novel intermediates. The second patent involves piperidinylamino-thieno[2,3-d] pyrimidine compounds, which are aimed at treating anxiety, depression, schizophrenia, neural injury, stroke, and migraine. This patent also includes methods of preparation and pharmaceutical salts.

Career Highlights

Throughout her career, Sharon Shachem has worked with several prominent companies in the pharmaceutical industry. Notable among these are Predix Pharmaceuticals Holdings, Inc. and Epix Delaware, Inc. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Shachem has collaborated with various professionals in her field, including Dale S. Dhanoa and Oren Becker. These collaborations have likely enriched her research and development efforts, leading to her successful patent applications.

Conclusion

Sharon Shachem's contributions to the field of pharmaceuticals through her innovative patents demonstrate her commitment to advancing medical science. Her work has the potential to improve the lives of many individuals suffering from central nervous system disorders.